Cargando…

Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells

Favipiravir (T-705), used against influenza viruses, is approved for emergency use in many countries for the treatment of COVID-19. The frequent adverse effects of favipiravir are related with the gastrointestinal system, however, studies suggest a positive association of favipiravir on QTc prolonga...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunaydin-Akyildiz, Aysenur, Aksoy, Nergis, Boran, Tugce, Ilhan, Emine Nihan, Ozhan, Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492396/
https://www.ncbi.nlm.nih.gov/pubmed/36152797
http://dx.doi.org/10.1016/j.toxlet.2022.09.011
_version_ 1784793471167496192
author Gunaydin-Akyildiz, Aysenur
Aksoy, Nergis
Boran, Tugce
Ilhan, Emine Nihan
Ozhan, Gul
author_facet Gunaydin-Akyildiz, Aysenur
Aksoy, Nergis
Boran, Tugce
Ilhan, Emine Nihan
Ozhan, Gul
author_sort Gunaydin-Akyildiz, Aysenur
collection PubMed
description Favipiravir (T-705), used against influenza viruses, is approved for emergency use in many countries for the treatment of COVID-19. The frequent adverse effects of favipiravir are related with the gastrointestinal system, however, studies suggest a positive association of favipiravir on QTc prolongation, which can cause cardiotoxicity. Also, there are reports of skin reactions such as angioedema due to favipiravir. Despite the several adverse effects, studies examining the drug’s effects at the molecular level are insufficient, e.g., the genotoxic and oxidative stress-inducing effects of favipiravir, which are among the primary mechanisms of drug-induced toxicity. The cytotoxicity of favipiravir was analyzed with the measurement of the ATP content in H9c2 cardiomyoblasts and CCD-1079Sk skin fibroblasts. The ATP level decreased starting from 200 µM. The inhibitory effect on the mitochondrial electron transport chain enzymes complex I and complex V was also evaluated where favipiravir showed significant enzyme inhibitory effects in the highest concentration studied. A molecular docking study evaluating the interaction between favipiravir-RTP and mitochondrial DNA polymerase (POLG1) was done. The relationship of favipiravir with oxidative stress was examined by measuring glutathione (GSH) and protein carbonyl levels which were observed higher after drug treatment compared to the control group. The genotoxicity study was done using the Comet assay and increase in DNA tail has been detected. Furthermore, 8-OHdG levels were measured higher in favipiravir treated cells indicating oxidative DNA damage. Favipiravir induced oxidative stress leading to DNA damage in cardiomyoblast cells and fibroblastic skin cells. Oxidative stress and DNA damage might eventually lead to organ-specific damage such as cardiotoxicity and dermal toxicity. Considering the increased use of favipiravir in recent years, and that oxidative stress and genotoxicity are two important indicators of drug-induced toxicity, the obtained results are worth attention.
format Online
Article
Text
id pubmed-9492396
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-94923962022-09-22 Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells Gunaydin-Akyildiz, Aysenur Aksoy, Nergis Boran, Tugce Ilhan, Emine Nihan Ozhan, Gul Toxicol Lett Article Favipiravir (T-705), used against influenza viruses, is approved for emergency use in many countries for the treatment of COVID-19. The frequent adverse effects of favipiravir are related with the gastrointestinal system, however, studies suggest a positive association of favipiravir on QTc prolongation, which can cause cardiotoxicity. Also, there are reports of skin reactions such as angioedema due to favipiravir. Despite the several adverse effects, studies examining the drug’s effects at the molecular level are insufficient, e.g., the genotoxic and oxidative stress-inducing effects of favipiravir, which are among the primary mechanisms of drug-induced toxicity. The cytotoxicity of favipiravir was analyzed with the measurement of the ATP content in H9c2 cardiomyoblasts and CCD-1079Sk skin fibroblasts. The ATP level decreased starting from 200 µM. The inhibitory effect on the mitochondrial electron transport chain enzymes complex I and complex V was also evaluated where favipiravir showed significant enzyme inhibitory effects in the highest concentration studied. A molecular docking study evaluating the interaction between favipiravir-RTP and mitochondrial DNA polymerase (POLG1) was done. The relationship of favipiravir with oxidative stress was examined by measuring glutathione (GSH) and protein carbonyl levels which were observed higher after drug treatment compared to the control group. The genotoxicity study was done using the Comet assay and increase in DNA tail has been detected. Furthermore, 8-OHdG levels were measured higher in favipiravir treated cells indicating oxidative DNA damage. Favipiravir induced oxidative stress leading to DNA damage in cardiomyoblast cells and fibroblastic skin cells. Oxidative stress and DNA damage might eventually lead to organ-specific damage such as cardiotoxicity and dermal toxicity. Considering the increased use of favipiravir in recent years, and that oxidative stress and genotoxicity are two important indicators of drug-induced toxicity, the obtained results are worth attention. Elsevier B.V. 2022-12-01 2022-09-22 /pmc/articles/PMC9492396/ /pubmed/36152797 http://dx.doi.org/10.1016/j.toxlet.2022.09.011 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gunaydin-Akyildiz, Aysenur
Aksoy, Nergis
Boran, Tugce
Ilhan, Emine Nihan
Ozhan, Gul
Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
title Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
title_full Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
title_fullStr Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
title_full_unstemmed Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
title_short Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
title_sort favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492396/
https://www.ncbi.nlm.nih.gov/pubmed/36152797
http://dx.doi.org/10.1016/j.toxlet.2022.09.011
work_keys_str_mv AT gunaydinakyildizaysenur favipiravirinducesoxidativestressandgenotoxicityincardiacandskincells
AT aksoynergis favipiravirinducesoxidativestressandgenotoxicityincardiacandskincells
AT borantugce favipiravirinducesoxidativestressandgenotoxicityincardiacandskincells
AT ilhaneminenihan favipiravirinducesoxidativestressandgenotoxicityincardiacandskincells
AT ozhangul favipiravirinducesoxidativestressandgenotoxicityincardiacandskincells